HK2	Hexokinase 2
PFK	Phosphofructokinase
PKM2	Pyruvate kinase M2
LDHA	Lactate dehydrogenase A
OXPHOS	Oxidative phosphorylation
TME	Tumor microenvironment
GLUTs	Glucose transporters
HK	Hexokinase
PK	Pyruvate kinase
LDH	Lactate dehydrogenase
PTMs	Post-translational modifications
HIF-1α	Hypoxia-Inducible Factor-1α
GLUT1	Glucose transporter type 1
PFKFB3	Enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3
PDK	Pyruvate dehydrogenase kinase
F-2,6-BP	Fructose-2,6-bisphosphate
PFK1	Phosphofructokinase 1
PGAM1	Phosphoglycerate mutase 1
PHD	Prolyl hydroxylase
G6P	Glucose-6-phosphate
HCC	Hepatocellular carcinoma
VDAC	Voltage-dependent anion channel
mPTP	Mitochondrial permeability transition pore
RCC	Renal cell carcinoma
ATC	Anaplastic thyroid carcinoma
PEP	Phosphoenolpyruvate
PPP	Pentose phosphate pathway
MDSCs	Myeloid-derived suppressor cells
PDH	Pyruvate dehydrogenase
DCA	Dichloroacetate
CAFs	Cancer-Associated Fibroblasts
TAMs	Tumor-Associated Macrophages
GPR81	G Protein-Coupled Receptor 81
CTLs	Cytotoxic T Lymphocytes
NK	Natural Killer
Tregs	Regulatory T cells
AMPK	AMP-Activated Protein Kinase
MCTs	Monocarboxylate transporters
2-DG	2-Deoxyglucose
ROS	Reactive oxygen species
3-BP	3-Bromopyruvate
DCs	Dendritic cells
MDR	Multi-drug resistance
ABC	ATP-binding cassette
RT	Radiotherapy
PDAC	Pancreatic ductal adenocarcinoma
GBM	Glioblastoma
TMZ	Temozolomide
HR	Homologous recombination repair
ICIs	Immune checkpoint inhibitors
PTT	Photothermal therapy
PDT	Photodynamic therapy
PDA	Polydopamine
NSCLC	Non-small-cell lung cancer
ADCC	Antibody-dependent cellular cytotoxicity
ENO2	Enolase 2
GAPDH	Glyceraldehyde-3-Phosphate Dehydrogenase
NEPC	Neuroendocrine prostate cancer